- call +1-201-465-4211
- email sales@mrinsights.biz
Assisted Reproductive Technology (ART) is the technology used to achieve pregnancy in procedures such as fertility medication, in vitro fertilization and surrogacy. It is reproductive technology used primarily for infertility treatments, and is also known as fertility treatment. It mainly belongs to the field of reproductive endocrinology and infertility, and may also include intracytoplasmic sperm injection (ICSI) and cryopreservation. Some forms of ART are also used with regard to fertile couples for genetic reasons (preimplantation genetic diagnosis). ART is also used for couples who are discordant for certain communicable diseases; for example, HIV to reduce the risk of infection when a pregnancy is desired.
Scope of the Report:
This report studies the Assisted Reproductive Technology (ART) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Assisted Reproductive Technology (ART) market by product type and applications/end industries.
North America is also expected to witness growth in the coming years. This is due to people awareness towards various fertility options, government support for the in-vitro fertilization and various technological and procedure up gradation. For instance, in August 2015 Ovascience’s treatment named AUGMENT has been reported to have rejuvenated women’s aging egg cells and provided benefits to eggs with poor quality. In February 2015, the scientist of U.S. who invented the three parent IVF procedure requested the Food and Drug Administration (FDA) to grant permission for its clinical trials as age related infertility.
The global Assisted Reproductive Technology (ART) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Assisted Reproductive Technology (ART).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Irvine Scientific
Origio a/s
Vitro Life
Esco Micro Pte. Ltd.
IVFtech ApS
Research Instruments
Genea Limited
Smiths Medical
Thermo Fisher Scientific, Inc.
Cook Medical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Fresh Donor
Fresh Nondonor
Frozen Donor
Frozen Nondonor
Egg/Embryo bank
Market Segment by Applications, can be divided into
Women Younger Than Age 35
Women Older Than Age 35
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Assisted Reproductive Technology (ART) Market Overview
1.1 Product Overview and Scope of Assisted Reproductive Technology (ART)
1.2 Classification of Assisted Reproductive Technology (ART) by Types
1.2.1 Global Assisted Reproductive Technology (ART) Revenue Comparison by Types (2017-2023)
1.2.2 Global Assisted Reproductive Technology (ART) Revenue Market Share by Types in 2017
1.2.3 Fresh Donor
1.2.4 Fresh Nondonor
1.2.5 Frozen Donor
1.2.6 Frozen Nondonor
1.2.7 Egg/Embryo bank
1.3 Global Assisted Reproductive Technology (ART) Market by Application
1.3.1 Global Assisted Reproductive Technology (ART) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Women Younger Than Age 35
1.3.3 Women Older Than Age 35
1.4 Global Assisted Reproductive Technology (ART) Market by Regions
1.4.1 Global Assisted Reproductive Technology (ART) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Assisted Reproductive Technology (ART) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Assisted Reproductive Technology (ART) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Assisted Reproductive Technology (ART) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Assisted Reproductive Technology (ART) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Assisted Reproductive Technology (ART) Status and Prospect (2013-2023)
1.5 Global Market Size of Assisted Reproductive Technology (ART) (2013-2023)
2 Manufacturers Profiles
2.1 Irvine Scientific
2.1.1 Business Overview
2.1.2 Assisted Reproductive Technology (ART) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Irvine Scientific Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Origio a/s
2.2.1 Business Overview
2.2.2 Assisted Reproductive Technology (ART) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Origio a/s Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2016-2017)
2.3 Vitro Life
2.3.1 Business Overview
2.3.2 Assisted Reproductive Technology (ART) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Vitro Life Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Esco Micro Pte. Ltd.
2.4.1 Business Overview
2.4.2 Assisted Reproductive Technology (ART) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Esco Micro Pte. Ltd. Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2016-2017)
2.5 IVFtech ApS
2.5.1 Business Overview
2.5.2 Assisted Reproductive Technology (ART) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 IVFtech ApS Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2016-2017)
2.6 Research Instruments
2.6.1 Business Overview
2.6.2 Assisted Reproductive Technology (ART) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Research Instruments Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2016-2017)
2.7 Genea Limited
2.7.1 Business Overview
2.7.2 Assisted Reproductive Technology (ART) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Genea Limited Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2016-2017)
2.8 Smiths Medical
2.8.1 Business Overview
2.8.2 Assisted Reproductive Technology (ART) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Smiths Medical Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2016-2017)
2.9 Thermo Fisher Scientific, Inc.
2.9.1 Business Overview
2.9.2 Assisted Reproductive Technology (ART) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Thermo Fisher Scientific, Inc. Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2016-2017)
2.10 Cook Medical
2.10.1 Business Overview
2.10.2 Assisted Reproductive Technology (ART) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cook Medical Assisted Reproductive Technology (ART) Revenue, Gross Margin and Market Share (2016-2017)
3 Global Assisted Reproductive Technology (ART) Market Competition, by Players
3.1 Global Assisted Reproductive Technology (ART) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Assisted Reproductive Technology (ART) Players Market Share
3.2.2 Top 10 Assisted Reproductive Technology (ART) Players Market Share
3.3 Market Competition Trend
4 Global Assisted Reproductive Technology (ART) Market Size by Regions
4.1 Global Assisted Reproductive Technology (ART) Revenue and Market Share by Regions
4.2 North America Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
4.3 Europe Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
4.5 South America Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
5 North America Assisted Reproductive Technology (ART) Revenue by Countries
5.1 North America Assisted Reproductive Technology (ART) Revenue by Countries (2013-2018)
5.2 USA Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
5.3 Canada Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
5.4 Mexico Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
6 Europe Assisted Reproductive Technology (ART) Revenue by Countries
6.1 Europe Assisted Reproductive Technology (ART) Revenue by Countries (2013-2018)
6.2 Germany Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
6.3 UK Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
6.4 France Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
6.5 Russia Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
6.6 Italy Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Assisted Reproductive Technology (ART) Revenue by Countries
7.1 Asia-Pacific Assisted Reproductive Technology (ART) Revenue by Countries (2013-2018)
7.2 China Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
7.3 Japan Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
7.4 Korea Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
7.5 India Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
8 South America Assisted Reproductive Technology (ART) Revenue by Countries
8.1 South America Assisted Reproductive Technology (ART) Revenue by Countries (2013-2018)
8.2 Brazil Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
8.3 Argentina Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
8.4 Colombia Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Assisted Reproductive Technology (ART) by Countries
9.1 Middle East and Africa Assisted Reproductive Technology (ART) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
9.3 UAE Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
9.4 Egypt Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
9.6 South Africa Assisted Reproductive Technology (ART) Revenue and Growth Rate (2013-2018)
10 Global Assisted Reproductive Technology (ART) Market Segment by Type
10.1 Global Assisted Reproductive Technology (ART) Revenue and Market Share by Type (2013-2018)
10.2 Global Assisted Reproductive Technology (ART) Market Forecast by Type (2018-2023)
10.3 Fresh Donor Revenue Growth Rate (2013-2023)
10.4 Fresh Nondonor Revenue Growth Rate (2013-2023)
10.5 Frozen Donor Revenue Growth Rate (2013-2023)
10.6 Frozen Nondonor Revenue Growth Rate (2013-2023)
10.7 Egg/Embryo bank Revenue Growth Rate (2013-2023)
11 Global Assisted Reproductive Technology (ART) Market Segment by Application
11.1 Global Assisted Reproductive Technology (ART) Revenue Market Share by Application (2013-2018)
11.2 Assisted Reproductive Technology (ART) Market Forecast by Application (2018-2023)
11.3 Women Younger Than Age 35 Revenue Growth (2013-2018)
11.4 Women Older Than Age 35 Revenue Growth (2013-2018)
12 Global Assisted Reproductive Technology (ART) Market Size Forecast (2018-2023)
12.1 Global Assisted Reproductive Technology (ART) Market Size Forecast (2018-2023)
12.2 Global Assisted Reproductive Technology (ART) Market Forecast by Regions (2018-2023)
12.3 North America Assisted Reproductive Technology (ART) Revenue Market Forecast (2018-2023)
12.4 Europe Assisted Reproductive Technology (ART) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Assisted Reproductive Technology (ART) Revenue Market Forecast (2018-2023)
12.6 South America Assisted Reproductive Technology (ART) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Assisted Reproductive Technology (ART) Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Assisted Reproductive Technology (ART) Picture
Table Product Specifications of Assisted Reproductive Technology (ART)
Table Global Assisted Reproductive Technology (
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
